Facet Biotech (FACT) Again Rejects Biogen Idec Takeover Offer
Tweet Send to a Friend
In response to a extension of the $14.50/share tender offer from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
